Champions Oncology (CSBR) Reports Q4 Loss of $0.15/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/5/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CSBR Hot Sheet
Price: $4.83 --0%
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
KTB, CABO, FDUS, More
Financial Fact:
Loss from operations: -2.52M
Today's EPS Names:
KTB, CABO, FDUS, More
Join SI Premium – FREE
Champions Oncology (NASDAQ: CSBR) reported Q4 EPS of ($0.15), versus ($0.24) reported last year. Revenue for the quarter came in at $3.72 million, versus $2.8 million reported last year.
For earnings history and earnings-related data on Champions Oncology (CSBR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Ardent Health Partners, Inc. (ARDT) Tops Q3 EPS by 8c; offers guidance
- NewAmsterdam Pharma Company N.V. (NAMS) Tops Q3 EPS by 35c
- Veracyte (VCYT) Tops Q3 EPS by 10c ; Offers Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
